menu search

Ardelyx Presents Positive Data Further Supporting Efficacy and Safety of XPHOZAH® (tenapanor) at National Kidney Foundation 2023 Spring Clinical Meetings

Ardelyx Presents Positive Data Further Supporting Efficacy and Safety of XPHOZAH® (tenapanor) at National Kidney Foundation 2023 Spring Clinical Meetings
Three posters support the important role that XPHOZAH, a novel phosphate absorption inhibitor, could potentially play in the treatment of hyperphosphatemia XPHOZAH consistently lowered serum phosphate in patients, independent of race Patients with chronic kidney disease (CKD) on maintenance dialysis who responded to treatment for hyperphosphatemia had comparable serum phosphate reductions with XPHOZAH or sevelamer […] The post Ardelyx Presents Positive Data Further Supporting Efficacy and Safety... Read More
Posted: Apr 12 2023, 20:05
Author Name: forextv
Views: 102168

Search within

Pages Search Results: